These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biochemical substrates of mental disturbances in Parkinson's disease. Agid Y; Ruberg M; Dubois B; Javoy-Agid F Adv Neurol; 1984; 40():211-8. PubMed ID: 6695597 [No Abstract] [Full Text] [Related]
4. Foreword. The clinical aspects of deficit in dopaminergic ways. Gessa GL; Kasper S Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():2 p following table of contents. PubMed ID: 12685915 [No Abstract] [Full Text] [Related]
6. [Various new trends of biochemical research in psychiatry]. Hanzlĭcĕk J Cesk Psychiatr; 1974 Dec; 70(6):393-400. PubMed ID: 4461169 [No Abstract] [Full Text] [Related]
7. The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Breese GR; Knapp DJ; Criswell HE; Moy SS; Papadeas ST; Blake BL Brain Res Brain Res Rev; 2005 Feb; 48(1):57-73. PubMed ID: 15708628 [TBL] [Abstract][Full Text] [Related]
8. [The problem of reinforcement. From behavioural control to neurochemical background and the development of psychopathologies]. Grigor'ian GA Zh Vyssh Nerv Deiat Im I P Pavlova; 2005; 55(6):747-61. PubMed ID: 16396481 [TBL] [Abstract][Full Text] [Related]
10. Time and the dopamine hypothesis. Aldenhoff JB Br J Psychiatry; 1988 May; 152():717-9. PubMed ID: 3167457 [No Abstract] [Full Text] [Related]
11. Back to where it all started: monoamines and behavior--from drug responses to genes. Licinio J; Wong ML Mol Psychiatry; 2004 May; 9(5):427. PubMed ID: 15118733 [No Abstract] [Full Text] [Related]
12. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders. Wood MD; Wren PB Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035 [TBL] [Abstract][Full Text] [Related]
13. [Biogenic amines (cerebral or cellular localization, influence of various chemical factors)]. Schrammowa H; Rybakowski J Psychiatr Pol; 1972; 6(1):73-9. PubMed ID: 4622259 [No Abstract] [Full Text] [Related]
14. The impact of scientific models on clinical psychopharmacology: a psychiatrist's view. Cole JO Semin Psychiatry; 1972 Aug; 4(3):261-4. PubMed ID: 4680224 [No Abstract] [Full Text] [Related]
15. Biogenic amines metabolism and blood chemistry of psychiatric patients. Ebuehi OA; Bishop SA; Fanmuyiwa OO; Akinwande AI; Ladenegan OA Afr J Med Med Sci; 2001 Dec; 30(4):269-73. PubMed ID: 14510102 [TBL] [Abstract][Full Text] [Related]
17. [Swedish research in frontline. Positron emission tomography shows the brain's receptor functions in psychiatric diseases]. Farde L; Sedvall G Lakartidningen; 1984 Nov; 81(48):4519-21. PubMed ID: 6097782 [No Abstract] [Full Text] [Related]
18. Concept maps and canonical models in neuropsychiatry. Marin-Sanguino A; del Rosario RC; Mendoza ER Pharmacopsychiatry; 2009 May; 42 Suppl 1():S110-7. PubMed ID: 19434549 [TBL] [Abstract][Full Text] [Related]
19. Response threshold to levodopa in psychiatric patients. Sathananthan G; Angrist BM; Gershon S Biol Psychiatry; 1973 Oct; 7(2):139-46. PubMed ID: 4584028 [No Abstract] [Full Text] [Related]
20. Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders. Pérez-Neri I; Montes S; Ojeda-López C; Ramírez-Bermúdez J; Ríos C Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1118-30. PubMed ID: 18280022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]